Fusion protein
OwnerRobin Shattock, Yoann Aldon +1inventors
InventorsRobin Shattock, Yoann Aldon, Paul McKay
Life of this patent
Estimating the term…
Abstract
The invention relates to fusion proteins, and to the use of fusion proteins (or genetic constructs or vectors encoding such fusion proteins) to vaccinate against viral infections. The invention extends to pharmaceutical compositions comprising such fusion proteins or constructs for preventing and treating viral infections, and to methods and uses thereof.
Claims15
A fusion protein comprising an antigen, and a Paramyxovirus or Orthomyxovirus transmembrane domain (TMD) and/or a Paramyxovirus or Orthomyxovirus cytoplasmic tail (CT).
A fusion protein suitable for forming a virus like particle (VLP), the fusion protein comprising a Paramyxovirus or Orthomyxovirus matrix protein and a membrane targeting signal (MTS).
15-31. (canceled)
Dependencies are inferred from the claim text.